Multicenter randomized controlled clinical trial of Tailin formulation combined with prolonged, low-dose antimicrobial therapy for recurrent urinary tract infectio

Not Applicable

• Conditions: recurrent urinary tract infection

• Registration Number: ITMCTR2100004240
• Lead Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. In line with the RUTI diagnostic criteria of Western medicine;
2. In line with the diagnostic criteria of traditional Chinese medicine;
3. between the ages of 18 and 75;
4. Voluntarily accept treatment and sign informed consent.

Exclusion Criteria

1. The first episode of acute urinary tract infection;
2. Imaging examination found urinary tract congenital malformation, renal pelvis stones and other lesions;
3. Urinary tract syndrome;
4. Patients with stage 4-5 chronic kidney disease (CKD) (i.e. EGFR <30ml/min);
5. Patients with severe heart, liver function damage or diabetes need immediate treatment;
6. Patients who are allergic to two antibiotics in the antimicrobial therapy in this experiment;
7. Pregnant or nursing women (women of childbearing age need to do urine HCG test to determine whether there is pregnancy);
8. Severe central nervous system diseases;
9. Drugs within 3 months.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
GOT;Urine ß2-MG;Scr;UNAG/UCR;GPT;BUN;

Secondary Outcome Measures

Name	Time	Method
ECG;blood routine examination;